Logo image of IUI1.DE

INTUITIVE SURGICAL INC (IUI1.DE) Stock Fundamental Analysis

Europe - Frankfurt Stock Exchange - FRA:IUI1 - US46120E6023 - Common Stock

439.1 EUR
-6.75 (-1.51%)
Last: 1/27/2026, 7:00:00 PM
Fundamental Rating

5

Overall IUI1 gets a fundamental rating of 5 out of 10. We evaluated IUI1 against 63 industry peers in the Health Care Equipment & Supplies industry. IUI1 scores excellent points on both the profitability and health parts. This is a solid base for a good stock. While showing a medium growth rate, IUI1 is valued expensive at the moment. These ratings would make IUI1 suitable for quality investing!


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

  • IUI1 had positive earnings in the past year.
  • In the past year IUI1 had a positive cash flow from operations.
  • Of the past 5 years IUI1 4 years were profitable.
  • IUI1 had a positive operating cash flow in 4 of the past 5 years.
IUI1.DE Yearly Net Income VS EBIT VS OCF VS FCFIUI1.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

1.2 Ratios

  • With an excellent Return On Assets value of 14.19%, IUI1 belongs to the best of the industry, outperforming 92.06% of the companies in the same industry.
  • IUI1's Return On Equity of 16.12% is amongst the best of the industry. IUI1 outperforms 84.13% of its industry peers.
  • The Return On Invested Capital of IUI1 (11.69%) is better than 84.13% of its industry peers.
  • IUI1 had an Average Return On Invested Capital over the past 3 years of 9.53%. This is in line with the industry average of 9.95%.
  • The last Return On Invested Capital (11.69%) for IUI1 is above the 3 year average (9.53%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 14.19%
ROE 16.12%
ROIC 11.69%
ROA(3y)11.41%
ROA(5y)11.26%
ROE(3y)13.21%
ROE(5y)12.97%
ROIC(3y)9.53%
ROIC(5y)9.27%
IUI1.DE Yearly ROA, ROE, ROICIUI1.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

  • The Profit Margin of IUI1 (28.58%) is better than 98.41% of its industry peers.
  • In the last couple of years the Profit Margin of IUI1 has declined.
  • Looking at the Operating Margin, with a value of 29.44%, IUI1 belongs to the top of the industry, outperforming 96.83% of the companies in the same industry.
  • IUI1's Operating Margin has declined in the last couple of years.
  • IUI1's Gross Margin of 66.38% is fine compared to the rest of the industry. IUI1 outperforms 73.02% of its industry peers.
  • IUI1's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 29.44%
PM (TTM) 28.58%
GM 66.38%
OM growth 3Y-4.19%
OM growth 5Y-1.68%
PM growth 3Y-2.34%
PM growth 5Y-2.02%
GM growth 3Y-0.91%
GM growth 5Y-0.58%
IUI1.DE Yearly Profit, Operating, Gross MarginsIUI1.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

7

2. Health

2.1 Basic Checks

  • IUI1 has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • IUI1 has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
IUI1.DE Yearly Shares OutstandingIUI1.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
IUI1.DE Yearly Total Debt VS Total AssetsIUI1.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

  • IUI1 has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z N/A
ROIC/WACC1.17
WACC10%
IUI1.DE Yearly LT Debt VS Equity VS FCFIUI1.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.3 Liquidity

  • IUI1 has a Current Ratio of 4.97. This indicates that IUI1 is financially healthy and has no problem in meeting its short term obligations.
  • With an excellent Current ratio value of 4.97, IUI1 belongs to the best of the industry, outperforming 96.83% of the companies in the same industry.
  • IUI1 has a Quick Ratio of 4.20. This indicates that IUI1 is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 4.20, IUI1 belongs to the top of the industry, outperforming 96.83% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 4.97
Quick Ratio 4.2
IUI1.DE Yearly Current Assets VS Current LiabilitesIUI1.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

5

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 21.83% over the past year.
  • The Earnings Per Share has been growing by 21.42% on average over the past years. This is a very strong growth
EPS 1Y (TTM)21.83%
EPS 3Y23.94%
EPS 5Y21.42%
EPS Q2Q%14.48%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%18.76%

3.2 Future

  • IUI1 is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 15.07% yearly.
  • The Revenue is expected to grow by 12.31% on average over the next years. This is quite good.
EPS Next Y11.25%
EPS Next 2Y13.22%
EPS Next 3Y13.64%
EPS Next 5Y15.07%
Revenue Next Year15.2%
Revenue Next 2Y14.36%
Revenue Next 3Y13.92%
Revenue Next 5Y12.31%

3.3 Evolution

  • Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
IUI1.DE Yearly Revenue VS EstimatesIUI1.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5B 10B 15B 20B
IUI1.DE Yearly EPS VS EstimatesIUI1.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5 10 15 20

2

4. Valuation

4.1 Price/Earnings Ratio

  • IUI1 is valuated quite expensively with a Price/Earnings ratio of 58.24.
  • Compared to the rest of the industry, the Price/Earnings ratio of IUI1 is on the same level as its industry peers.
  • The average S&P500 Price/Earnings ratio is at 28.87. IUI1 is valued rather expensively when compared to this.
  • IUI1 is valuated quite expensively with a Price/Forward Earnings ratio of 52.31.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of IUI1 indicates a slightly more expensive valuation: IUI1 is more expensive than 69.84% of the companies listed in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 25.96, IUI1 is valued quite expensively.
Industry RankSector Rank
PE 58.24
Fwd PE 52.31
IUI1.DE Price Earnings VS Forward Price EarningsIUI1.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, IUI1 is valued a bit more expensive than the industry average as 66.67% of the companies are valued more cheaply.
  • The rest of the industry has a similar Price/Free Cash Flow ratio as IUI1.
Industry RankSector Rank
P/FCF 81.12
EV/EBITDA 52.06
IUI1.DE Per share dataIUI1.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • IUI1 has a very decent profitability rating, which may justify a higher PE ratio.
  • IUI1's earnings are expected to grow with 13.64% in the coming years. This may justify a more expensive valuation.
PEG (NY)5.18
PEG (5Y)2.72
EPS Next 2Y13.22%
EPS Next 3Y13.64%

0

5. Dividend

5.1 Amount

  • No dividends for IUI1!.
Industry RankSector Rank
Dividend Yield 0%

INTUITIVE SURGICAL INC / IUI1.DE FAQ

Can you provide the ChartMill fundamental rating for INTUITIVE SURGICAL INC?

ChartMill assigns a fundamental rating of 5 / 10 to IUI1.DE.


Can you provide the valuation status for INTUITIVE SURGICAL INC?

ChartMill assigns a valuation rating of 2 / 10 to INTUITIVE SURGICAL INC (IUI1.DE). This can be considered as Overvalued.


Can you provide the profitability details for INTUITIVE SURGICAL INC?

INTUITIVE SURGICAL INC (IUI1.DE) has a profitability rating of 7 / 10.


Can you provide the financial health for IUI1 stock?

The financial health rating of INTUITIVE SURGICAL INC (IUI1.DE) is 7 / 10.